Response: Selective serotin reputake inhibitors in children and adolescents

Simple item page
dc.contributor.authorHawkridge, S M
dc.contributor.authorSeedat, S
dc.contributor.authorEmsley, R
dc.contributor.authorCarey, P
dc.contributor.authorStein, D J
dc.date.accessioned2017-05-25T13:17:38Z
dc.date.available2017-05-25T13:17:38Z
dc.date.issued2006
dc.date.updated2016-01-08T10:10:56Z
dc.description.abstractThe introduction of the selective serotonin reuptake inhibitors (SSRIs) was widely viewed as an important advance in clinical psychopharmacology, not only because of their broad-spectrum efficacy but also because of their tolerability and safety advantages, particularly compared with the older tricyclic antidepressants (TCAs) and monoamine oxide inhibitors (MAOIs). Subsequently there has been considerable controversy about this class of agents, partly because of concerns about the extent to which they have been injudiciously prescribed for ‘cosmetic’ problems rather than for genuine psychopathology,1 and partly because of concerns regarding their adverse effects. Most recently, attention has been paid to the appropriate use of SSRIs in children and adolescents.
dc.identifierhttp://dx.doi.org/10.7196/SAMJ.993
dc.identifier.apacitationHawkridge, S. M., Seedat, S., Emsley, R., Carey, P., & Stein, D. J. (2006). Response: Selective serotin reputake inhibitors in children and adolescents. <i>South African Medical Journal</i>, http://hdl.handle.net/11427/24412en_ZA
dc.identifier.chicagocitationHawkridge, S M, S Seedat, R Emsley, P Carey, and D J Stein "Response: Selective serotin reputake inhibitors in children and adolescents." <i>South African Medical Journal</i> (2006) http://hdl.handle.net/11427/24412en_ZA
dc.identifier.citationHawkridge, S., Seedat, S., Emsley, R., Carey, P., & Stein, D. (2006). Selective serotonin reuptake inhibitors in children and adolescents. South African Medical Journal, 96(2), 82.
dc.identifier.ris TY - Journal Article AU - Hawkridge, S M AU - Seedat, S AU - Emsley, R AU - Carey, P AU - Stein, D J AB - The introduction of the selective serotonin reuptake inhibitors (SSRIs) was widely viewed as an important advance in clinical psychopharmacology, not only because of their broad-spectrum efficacy but also because of their tolerability and safety advantages, particularly compared with the older tricyclic antidepressants (TCAs) and monoamine oxide inhibitors (MAOIs). Subsequently there has been considerable controversy about this class of agents, partly because of concerns about the extent to which they have been injudiciously prescribed for ‘cosmetic’ problems rather than for genuine psychopathology,1 and partly because of concerns regarding their adverse effects. Most recently, attention has been paid to the appropriate use of SSRIs in children and adolescents. DA - 2006 DB - OpenUCT DP - University of Cape Town J1 - South African Medical Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2006 T1 - Response: Selective serotin reputake inhibitors in children and adolescents TI - Response: Selective serotin reputake inhibitors in children and adolescents UR - http://hdl.handle.net/11427/24412 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/24412
dc.identifier.vancouvercitationHawkridge SM, Seedat S, Emsley R, Carey P, Stein DJ. Response: Selective serotin reputake inhibitors in children and adolescents. South African Medical Journal. 2006; http://hdl.handle.net/11427/24412.en_ZA
dc.language.isoeng
dc.publisher.departmentDepartment of Paediatrics and Child Healthen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourceSouth African Medical Journal
dc.source.urihttp://www.samj.org.za/index.php/samj
dc.titleResponse: Selective serotin reputake inhibitors in children and adolescents
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hawkridge_Response_page82_2006.pdf
Size:
448.54 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles